Elite Pharmaceuticals ELTP
OTC ELTP
$0.36 +0.04 (+11.56%)
As of: Nov 16, 2026 · 2:29 PM EST

Elite Pharmaceuticals (ELTP) Operating Margin (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Operating Margin of 24.76% for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 2.15 percentage points from 22.61% a year earlier and up 1.49 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Operating Margin (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Operating Margin at Elite Pharmaceuticals was 25.32%, down 8.99 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 32.99%, up 9.67 percentage points from FY2025.

  • Annual Operating Margin has increased for three consecutive fiscal years, with a five-year change of +24.70 percentage points (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Operating Margin was 23.32% in FY2025 (+4.27 pp), 19.05% in FY2024 (+8.29 pp), 10.76% in FY2023 (-4.95 pp) and 15.72% in FY2022 (+7.43 pp).
  • Quarterly Operating Margin has run from a low of -4.48% in fiscal Q4 2023 to a high of 53.96% in fiscal Q1 2026 over five years.
  • On a year-over-year basis, Operating Margin increased in five of the last eight quarters, with an average year-over-year change of +2.38 percentage points.
  • The strongest year-over-year quarter for Operating Margin in the past five years was fiscal Q4 2022, with a gain of 35.39 percentage points; the weakest was fiscal Q1 2027, with a drop of 30.69 percentage points.
  • According to Business Quant data, Operating Margin for the three prior fiscal quarters was 23.27% (Q1 2027), 25.00% (Q4 2026) and 28.53% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,282.03 Bn 1,255.64 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 683.25 Bn 603.12 Bn 17.30 Bn 24.35%
3 AbbVie 521.57 Bn 489.58 Bn 13.12 Bn 36.01%
4 Merck 360.17 Bn 323.11 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.95 Bn 285.18 Bn - -
6 Astrazeneca 286.10 Bn 259.75 Bn 13.26 Bn 29.12%
7 Amgen 250.77 Bn 202.42 Bn 7.58 Bn 35.79%
8 Gilead Sciences 208.06 Bn 183.17 Bn 6.73 Bn 41.71%
9 Pfizer 164.93 Bn 112.29 Bn 12.56 Bn 32.98%
10 Elite Pharmaceuticals 384.54 Mn 257.95 Mn 15.99 Mn 24.76%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 24.76%
Jun 30, 2026 23.27%
Mar 31, 2026 25.00%
Dec 31, 2025 28.53%
Sep 30, 2025 22.61%
Jun 30, 2025 53.96%
Mar 31, 2025 34.86%
Dec 31, 2024 7.64%
Sep 30, 2024 18.46%
Jun 30, 2024 20.55%
Mar 31, 2024 20.77%
Dec 31, 2023 22.73%
Sep 30, 2023 13.60%
Jun 30, 2023 17.84%
Mar 31, 2023 -4.48%
Dec 31, 2022 21.18%
Sep 30, 2022 12.59%
Jun 30, 2022 13.33%
Mar 31, 2022 11.10%
Dec 31, 2021 20.40%
API Access

Elite Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY